EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 3.0

Tropheryma whipplei Pneumonia with Myelofibrosis: A Rare Actinomycetia Case Report and Literature Review

Junbao Liu iD, Xing Wang, Peitao Xie, Lisen Dong, Pu Bai iD, Yang Liu, Gang Chen iD, Duo Hao

Infection and Drug Resistance · 2026-10 · Volume 19 · 1-12

DOI: 10.2147/idr.s636054 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Infection and Drug Resistance, 2026-10. Verfasst von Junbao Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Ordos Central Hospital, Ordos, 017000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Tropheryma whippleimetagenomic next-generation sequencingpulmonary infectionreview

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, Ordos Central Hospital, Ordos, 017000, People's Republic of China.

ORCID-Profile: Junbao Liu, Pu Bai, Gang Chen

Zitieren

APA

Liu, J., Wang, X., Xie, P., Dong, L., Bai, P., Liu, Y., Chen, G., & Hao, D. (2026). Tropheryma whipplei Pneumonia with Myelofibrosis: A Rare Actinomycetia Case Report and Literature Review. Infection and Drug Resistance, Volume 19, 1-12. https://doi.org/10.2147/idr.s636054

Vancouver

Liu J, Wang X, Xie P, Dong L, Bai P, Liu Y, et al. Tropheryma whipplei Pneumonia with Myelofibrosis: A Rare Actinomycetia Case Report and Literature Review. Infection and Drug Resistance. 2026;Volume 19:1-12. doi:10.2147/idr.s636054

BibTeX
@article{Liu2026,
  author = {Liu, Junbao and Wang, Xing and Xie, Peitao and Dong, Lisen and Bai, Pu and Liu, Yang and Chen, Gang and Hao, Duo},
  title = {Tropheryma whipplei Pneumonia with Myelofibrosis: A Rare Actinomycetia Case Report and Literature Review},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--12},
  doi = {10.2147/idr.s636054}
}
Kostenlos starten →